UBS Group’s Cellectar Biosciences, Inc. CLRBW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-350
| Closed | – | – | 7399 |
|
|
2019
Q2 | $0 | Hold |
350
| – | – | ﹤0.01% | 7346 |
|
|
2019
Q1 | $0 | Sell |
350
-20
| -5% | – | ﹤0.01% | 7358 |
|
|
2018
Q4 | $0 | Sell |
370
-100
| -21% | – | ﹤0.01% | 7400 |
|
|
2018
Q3 | $0 | Hold |
470
| – | – | ﹤0.01% | 7335 |
|
|
2018
Q2 | $0 | Sell |
470
-100
| -18% | – | ﹤0.01% | 7306 |
|
|
2018
Q1 | $0 | Hold |
570
| – | – | ﹤0.01% | 7230 |
|
|
2017
Q4 | $0 | Hold |
570
| – | – | ﹤0.01% | 7115 |
|
|
2017
Q3 | $0 | Hold |
570
| – | – | ﹤0.01% | 7033 |
|
|
2017
Q2 | $0 | Buy |
570
+20
| +4% | – | ﹤0.01% | 7021 |
|
|
2017
Q1 | $0 | Buy |
550
+510
| +1,275% | – | ﹤0.01% | 6974 |
|
|
2016
Q4 | $0 | Buy |
+40
| New | – | ﹤0.01% | 7032 |
|
|
2016
Q3 | – | Sell |
-259
| Closed | – | – | 6982 |
|
|
2016
Q2 | $0 | Buy |
+259
| New | – | ﹤0.01% | 7032 |
|